MKI67 and neoplasm: In addition, HE and IHC analysis of xenograft tumors demonstrated that LPS treatment made no significant difference in Ki67 staining (a marker of cell proliferation), which might be the reason of that LPS might play two opposite roles when expressed on cancer cells versus immune cells, eventually representing relative moderate effects in tumor suppression (Fig. 12G and H).